Search form
Search
contact us
Navigation
home
boards
Jobs
job ratings
cp wire
medtech news
pharmagather
catering
advertise
whistleblower info
pharmaceutical fraud
medical device | DME fraud
clinical lab fraud
False Claims Act
Legal Help
login/register
You are here
Home
»
companies
» asthma
asthma
Upstream Bio Launches with $200M Series A Financing to Advance Novel Therapeutics for Allergic and Inflammatory Diseases
BioSpace
Thu, 06/2/22 - 10:35 am
Upstream Bio
funding
asthma
allergies
Masimo's (MASI) PVi Favored by New Study for Pediatric Patients
Yahoo/Zacks.com
Thu, 05/26/22 - 10:13 am
Masimo
Medtech
devices
PVi
pediatric
asthma
GSK 'schemed' FDA's drug-device approval pathway to deflect asthma inhaler generics, lawsuit claims
Fierce Pharma
Wed, 05/25/22 - 10:30 am
GSK
FDA
drug-device combos
Missouri
legal
asthma
inhalers
AstraZeneca, Avillion ‘first-in-class’ combination inhaler shines in Phase 3 trial
Pharmaforum
Mon, 05/16/22 - 10:24 am
AstraZeneca
Avillion
clinical trials
calbuterol/budesonide
inhalers
asthma
Teva suffers setback on in-house asthma program as a PhII study is halted early due to futility
Endpoints
Wed, 03/23/22 - 11:06 am
Teva Pharmaceutical
clinical trials
asthma
TEV-48574
AstraZeneca, Amgen tap Brand Institute in new naming twist for their freshly approved Tezspire
Fierce Pharma
Thu, 01/6/22 - 11:52 am
Amgen
AstraZeneca
Broad Institute
asthma
Tezspire
drug names
4D Pharma sees positive data from early stage asthma trial
Biopharma Reporter
Wed, 12/22/21 - 11:32 pm
4D Pharma
clinical trials
asthma
LBPs
Viatris gets shot to shed infringement claims in long-running patent kerfuffle on AstraZeneca's Symbicort
Fierce Pharma
Tue, 12/14/21 - 11:33 pm
Viatris
generics
Symbicort
AstraZeneca
patents
COPD
asthma
Take a deep breath: Asthma drug study failed to include Black and Puerto Rican children who could benefit most
Stat
Wed, 12/8/21 - 11:45 pm
Sanofi
Regeneron
asthma
pediatric
COVID-19
clinical trial diversity
Aiming to uproot the market for asthma attacks, AstraZeneca and Avillion tout two PhIII wins for inhaled combo drug
Endpoints
Thu, 09/9/21 - 10:58 am
AstraZeneca
Avillion
asthma
severe asthma
clinical trials
PT027
Amgen builds case for severe asthma drug tezepelumab
Pharmaforum
Mon, 09/6/21 - 09:11 pm
Amgen
AstraZeneca
tezepelumab
asthma
nasal polyps
AstraZeneca and Amgen quietly admit tezepelumab defeat as the Dupixent challenger heads to FDA
Endpoints
Thu, 07/29/21 - 11:10 am
AstraZeneca
Amgen
tezepelumab
asthma
Dupixent
Sanofi
Sanofi, touting new data, sees 'best-in-class' case for Dupixent in pediatric asthma
Fierce Pharma
Mon, 05/17/21 - 10:46 am
Sanofi
Dupixent
asthma
pediatric
Amgen, AstraZeneca's tezepelumab is looking for a slice of blockbuster asthma market dominated by Sanofi's Dupixent
Fierce Biotech
Thu, 05/13/21 - 10:57 am
Amgen
AstraZeneca
tezepelumab
asthma
severe asthma
Sanofi
Dupixent
FDA
Feds charge another CRO staffer with faking data in a GlaxoSmithKline pediatric asthma study
Endpoints
Wed, 05/12/21 - 11:09 am
GSK
asthma
clinical trial
fraud
CROs
Amgen asks FDA for approval of key asthma drug
BioPharma Dive
Mon, 05/10/21 - 08:15 pm
Amgen
FDA
asthma
tezepelumab
AstraZeneca, Amgen Breathing Easier with Optimistic Phase III Asthma Drug Results
BioSpace
Mon, 03/1/21 - 11:17 am
AstraZeneca
Amgen
clinical trials
severe asthma
asthma
antibodies
Amgen-AstraZeneca Experimental Asthma Drug Surprisingly Flops in Phase III
BioSpace
Tue, 12/22/20 - 10:47 am
Amgen
AstraZeneca
asthma
clinical trials
tezepelumab
Kinaset launches with $40M and a JAK inhibitor from Vectura's old pipeline
Endpoints
Mon, 11/30/20 - 10:20 am
Kinaset Therapeutics
asthma
Vectura
JAK inhibitors
Amgen, AstraZeneca's tezepelumab hits goal in asthma phase 3
Fierce Pharma
Tue, 11/10/20 - 10:41 am
Amgen
AstraZeneca
tezepelumab
asthma
severe asthma
clinical trials
Pages
« first
‹ previous
1
2
3
4
5
6
7
8
9
…
next ›
last »